We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Agilent, Merck and Danaher Invest $89 Million in Benchtop DNA Printer Technology

Product News   Jul 30, 2020

 
Agilent, Merck and Danaher Invest $89 Million in Benchtop DNA Printer Technology
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

AnteoTech Secures CE Certification for Its Versatile EuGeni Rapid Diagnostic Platform

Product News

AnteoTech has announced that its EuGeni™ Reader and accompanying COVID-19 Antigen Rapid Test (ART) have received Conformité Européene (CE) Mark registration as the company looks to progress with European distribution.

READ MORE

SGD Pharma Extends Sterinity Ready-To-Use Molded Glass Vials Range

Product News

SGD Pharma announces the continued expansion of its Ready-to-Use (RTU) Sterinity molded glass vial platform with the introduction of market-first amber glass 50ml volume option.

READ MORE

Mologic’s COVID-19 Rapid Antigen Self-Test Selected by NIH for RADx Initiative Funding

Product News

Mologic has announced that its rapid antigen self-test for COVID-19 has been selected by the Rapid Acceleration of Diagnostics initiative launched by the U.S. National Institutes of Health. The initiative aims to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE